Cresco Labs - CRLBF Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $20.33
  • Forecasted Upside: 916.67%
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$2.00
+0 (0.00%)

This chart shows the closing price for CRLBF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Cresco Labs Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CRLBF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CRLBF

Analyst Price Target is $20.33
▲ +916.67% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Cresco Labs in the last 3 months. The average price target is $20.33, with a high forecast of $34.00 and a low forecast of $2.00. The average price target represents a 916.67% upside from the last price of $2.00.

This chart shows the closing price for CRLBF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 3 polled investment analysts is to moderate buy stock in Cresco Labs. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/24/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/22/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/22/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/21/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/19/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/17/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/17/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/16/2024

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/14/2024Roth MkmBoost TargetNeutral ➝ Neutral$1.75 ➝ $2.00
3/13/2024Echelon Wealth PartnersUpgradeHold ➝ Buy
9/24/2023Atb Cap MarketsReiterated RatingOutperform
8/17/2023Stifel NicolausLower TargetC$2.00 ➝ C$1.50
8/16/2023Alliance Global PartnersLower TargetC$5.00 ➝ C$4.00
7/31/2023Stifel NicolausLower TargetC$2.25 ➝ C$2.00
3/17/2023Roth CapitalDowngradeBuy ➝ Neutral
3/17/2023Stifel NicolausLower TargetC$2.75 ➝ C$2.50
3/16/2023Echelon Wealth PartnersDowngradeBuy ➝ Hold
2/27/2023Piper SandlerDowngradeOverweight ➝ Neutral
2/24/2023Cantor FitzgeraldReiterated RatingOverweight$14.25
2/8/2023Stifel NicolausLower TargetC$4.75 ➝ C$2.75
12/30/2022Cantor FitzgeraldLower TargetOverweight$15.00 ➝ $14.25
12/20/2022CowenDowngradeOutperform ➝ Market Perform
12/20/2022CowenDowngradeOutperform ➝ Market Perform$7.00 ➝ $2.50
12/1/2022WedbushInitiated CoverageOutperform$4.50
10/28/2022BTIG ResearchReiterated RatingBuy
8/18/2022Canaccord Genuity GroupLower TargetC$9.50 ➝ C$8.00
8/18/2022Cantor FitzgeraldLower TargetOverweight$19.00 ➝ $15.00
8/18/2022Piper SandlerLower TargetOverweight$9.00 ➝ $6.00
8/17/2022Alliance Global PartnersLower TargetC$15.00 ➝ C$10.00
6/7/2022Pi FinancialReiterated RatingBuy
5/19/2022Canaccord Genuity GroupLower TargetC$12.00 ➝ C$9.50
5/19/2022Stifel NicolausLower TargetC$8.00 ➝ C$5.00
5/19/2022Alliance Global PartnersLower TargetC$19.00 ➝ C$15.00
5/18/2022Echelon Wealth PartnersReiterated RatingBuy
3/25/2022Canaccord Genuity GroupLower TargetC$15.00 ➝ C$12.00
3/24/2022Piper SandlerLower TargetOverweight$14.00 ➝ $9.00
3/23/2022Atb Cap MarketsReiterated RatingOutperform
11/23/2021Jefferies Financial GroupBoost TargetBuyC$33.00 ➝ C$36.00
11/15/2021Cantor FitzgeraldBoost TargetTop Pick ➝ Overweight$12.00 ➝ $19.00
11/3/2021Cantor FitzgeraldLower TargetOverweight$12.65 ➝ $12.00
11/1/2021Stifel NicolausLower TargetBuyC$34.00 ➝ C$30.00
8/5/2021Cantor FitzgeraldLower TargetOverweight$21.50 ➝ $13.50
7/7/2021Jefferies Financial GroupInitiated CoverageBuy$36.00
6/2/2021BTIG ResearchReiterated RatingBuyC$24.00
3/26/2021Stifel NicolausLower TargetBuy$36.00 ➝ $34.00
3/19/2021Stifel NicolausBoost TargetBuy$33.50 ➝ $36.00
3/8/2021BTIG ResearchInitiated CoverageBuy
2/25/2021Stifel NicolausBoost TargetBuy$21.50 ➝ $33.50
2/18/2021Alliance Global PartnersInitiated CoverageBuy$25.00
1/20/2021Cantor FitzgeraldBoost TargetOverweight$18.00 ➝ $21.00
1/18/2021Haywood SecuritiesBoost TargetNA$24.00
11/19/2020Piper SandlerBoost TargetOverweight$12.00 ➝ $14.00
11/19/2020Cantor FitzgeraldBoost TargetOverweight$16.00 ➝ $18.00
10/30/2020Cantor FitzgeraldBoost TargetOverweight$15.00 ➝ $16.00
8/21/2020Roth CapitalBoost TargetBuy$8.00 ➝ $11.00
8/21/2020Cantor FitzgeraldBoost TargetOverweight$11.00 ➝ $15.00
8/21/2020Piper SandlerBoost TargetOverweight$8.00 ➝ $12.00
7/22/2020Stifel NicolausInitiated CoverageBuy$10.00
6/12/2020Needham & Company LLCInitiated CoverageHold$4.20
5/27/2020Cantor FitzgeraldBoost TargetOverweight$8.00 ➝ $9.50
4/28/2020Cantor FitzgeraldLower TargetOverweight$10.00 ➝ $8.00
3/30/2020Cantor FitzgeraldLower TargetOverweight$12.00 ➝ $10.00
2/21/2020LADENBURG THALM/SH SHInitiated CoverageBuy
2/13/2020Cantor FitzgeraldInitiated CoverageOverweight$12.00
12/20/2019Roth CapitalInitiated CoverageBuy$12.00
9/13/2019CowenInitiated CoverageOutperform$14.00
8/12/2019Piper Sandler CompaniesInitiated CoverageOverweight ➝ Overweight$11.00
6/10/2019Compass PointInitiated CoverageBuy
(Data available from 4/16/2019 forward)

News Sentiment Rating

0.81 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 4 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/19/2023
  • 2 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/19/2023
  • 0 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/18/2023
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/18/2023
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/17/2024
  • 2 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
2/16/2024
  • 5 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
3/17/2024
  • 3 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/16/2024

Current Sentiment

  • 3 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.
Cresco Labs logo
Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company was incorporated in 1990 and is headquartered in Chicago, Illinois.
Read More

Today's Range

Now: $2.00
Low: $1.89
High: $2.05

50 Day Range

MA: $1.96
Low: $1.52
High: $2.52

52 Week Range

Now: $2.00
Low: $1.00
High: $2.77

Volume

766,572 shs

Average Volume

840,874 shs

Market Capitalization

$691.23 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.29

Frequently Asked Questions

What sell-side analysts currently cover shares of Cresco Labs?

The following sell-side analysts have issued stock ratings on Cresco Labs in the last year: Alliance Global Partners, Atb Cap Markets, Echelon Wealth Partners, Roth Mkm, and Stifel Nicolaus.
View the latest analyst ratings for CRLBF.

What is the current price target for Cresco Labs?

3 Wall Street analysts have set twelve-month price targets for Cresco Labs in the last year. Their average twelve-month price target is $20.33, suggesting a possible upside of 916.7%. Stifel Nicolaus has the highest price target set, predicting CRLBF will reach $34.00 in the next twelve months. Roth Mkm has the lowest price target set, forecasting a price of $2.00 for Cresco Labs in the next year.
View the latest price targets for CRLBF.

What is the current consensus analyst rating for Cresco Labs?

Cresco Labs currently has 1 hold rating and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for CRLBF.

What other companies compete with Cresco Labs?

How do I contact Cresco Labs' investor relations team?

Cresco Labs' physical mailing address is 400 West Erie Street, Chicago, IL 60654. The company's listed phone number is 312-929-0993 and its investor relations email address is [email protected]. The official website for Cresco Labs is www.crescolabs.com. Learn More about contacing Cresco Labs investor relations.